• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测头颈部癌根治性或辅助性放疗及全身治疗后早期死亡风险的列线图。

Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer.

作者信息

Raab Gabriel, Yu Yao, Sherman Eric, Wong Richard, Mell Loren K, Lee Nancy Y, Zakeri Kaveh

机构信息

Weill Cornell Medical College, New York, NY, USA.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Clin Transl Radiat Oncol. 2024 Jan 13;45:100725. doi: 10.1016/j.ctro.2024.100725. eCollection 2024 Mar.

DOI:10.1016/j.ctro.2024.100725
PMID:38304239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10832379/
Abstract

PURPOSE/OBJECTIVES: We sought to create nomograms to predict individual risk of early mortality, which can identify patients who require interventions to prevent early death.

METHODS

We included patients in the National Cancer Database with non-metastatic squamous cell carcinoma of the head and neck who received radiation and systemic therapy between 2004 and 2017 in the definitive or adjuvant setting. Early mortality was defined as any death less than 90 days after starting radiation. Multivariable logistic regression was used to assess the relationship between covariates and early mortality. Nomograms to predict the risk of early death were created for both the definitive and adjuvant settings.

RESULTS

Among 84,563 patients in the definitive group and 18,514 patients in the adjuvant group, rates of early mortality were 3.5 % (95 % CI 3.4-3.7 %) and 2.2 %, (95 % CI 1.9-2.4 %), respectively. Patients above the age of 70 had an early mortality rate of 7.8 % (95 % CI 7.3-8.2 %) in the definitive group and 4.4 % (95 % CI 3.6-5.4 %) in the adjuvant group. In the multivariable analysis, age, comorbidity, T and N category, and tumor site were associated with early mortality in both cohorts (p < 0.05 for all). Nomograms including age, comorbidity, T and N category and tumor site performed better than age alone at predicting early mortality (AUC for definitive group: 0.70 vs 0.66; AUC for adjuvant group: 0.71 vs 0.61).

CONCLUSION

Nomograms including age, comorbidity, T and N category and tumor site were developed to predict the risk of early death following definitive or adjuvant chemoradiation.

摘要

目的/目标:我们试图创建列线图以预测早期死亡的个体风险,该列线图能够识别需要采取干预措施以预防早期死亡的患者。

方法

我们纳入了国家癌症数据库中2004年至2017年间在根治性或辅助性治疗中接受放疗和全身治疗的非转移性头颈部鳞状细胞癌患者。早期死亡定义为开始放疗后90天内的任何死亡。采用多变量逻辑回归评估协变量与早期死亡之间的关系。为根治性和辅助性治疗设置分别创建了预测早期死亡风险的列线图。

结果

在根治性治疗组的84,563例患者和辅助性治疗组的18,514例患者中,早期死亡率分别为3.5%(95%CI 3.4 - 3.7%)和2.2%(95%CI 1.9 - 2.4%)。70岁以上患者在根治性治疗组的早期死亡率为7.8%(95%CI 7.3 - 8.2%),在辅助性治疗组为4.4%(95%CI 3.6 - 5.4%)。在多变量分析中,年龄、合并症、T和N分期以及肿瘤部位在两个队列中均与早期死亡相关(所有p值均<0.05)。包含年龄、合并症、T和N分期以及肿瘤部位的列线图在预测早期死亡方面比单独使用年龄表现更好(根治性治疗组AUC:0.70对0.66;辅助性治疗组AUC:0.71对0.61)。

结论

开发了包含年龄、合并症、T和N分期以及肿瘤部位的列线图,以预测根治性或辅助性放化疗后的早期死亡风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/9dd028606fcf/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/c327ee85d64b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/2e7b093a4406/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/11a527fe1c50/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/9d5f299dc4d6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/9dd028606fcf/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/c327ee85d64b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/2e7b093a4406/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/11a527fe1c50/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/9d5f299dc4d6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/10832379/9dd028606fcf/gr5.jpg

相似文献

1
Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer.预测头颈部癌根治性或辅助性放疗及全身治疗后早期死亡风险的列线图。
Clin Transl Radiat Oncol. 2024 Jan 13;45:100725. doi: 10.1016/j.ctro.2024.100725. eCollection 2024 Mar.
2
Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.列线图预测头颈部鳞状细胞癌术后延迟开始放疗的建立和验证。
JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):455-464. doi: 10.1001/jamaoto.2020.0222.
3
Nomogram for preoperative prediction of nodal extracapsular extension or positive surgical margins in oropharyngeal squamous cell carcinoma.用于预测口咽鳞状细胞癌淋巴结囊外侵犯或阳性手术切缘的列线图。
Oral Oncol. 2018 Aug;83:73-80. doi: 10.1016/j.oraloncology.2018.06.005. Epub 2018 Jun 13.
4
Selection of Head and Neck Cancer Patients for Intensive Therapy.头颈部癌症患者的强化治疗选择。
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):157-166. doi: 10.1016/j.ijrobp.2019.09.011. Epub 2019 Sep 30.
5
Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.手术切除后辅助放化疗治疗头颈部高危鳞状细胞癌老年患者:国家癌症数据库分析。
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):784-792. doi: 10.1016/j.ijrobp.2017.03.019. Epub 2017 Mar 18.
6
Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.头颈部鳞状细胞癌患者的癌症特异性死亡率和竞争死亡率:一项竞争风险分析。
Ann Surg Oncol. 2015 Jan;22(1):264-71. doi: 10.1245/s10434-014-3951-8. Epub 2014 Jul 30.
7
Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival.80岁以上晚期头颈部鳞状细胞癌老年患者根治性手术后辅助放疗对总生存期的影响。
Front Oncol. 2022 Sep 30;12:973245. doi: 10.3389/fonc.2022.973245. eCollection 2022.
8
The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.辅助治疗和头颈部基底样鳞状细胞癌原发解剖部位对生存的重要性:国家癌症数据库分析。
Clin Transl Oncol. 2020 Dec;22(12):2264-2274. doi: 10.1007/s12094-020-02370-2. Epub 2020 May 21.
9
A nomogram for predicting survival in Patients with oral tongue keratinized squamous cell carcinoma: A SEER-based study.基于 SEER 数据库的预测口腔舌部角化鳞状细胞癌患者生存的列线图。
J Stomatol Oral Maxillofac Surg. 2023 Sep;124(4):101422. doi: 10.1016/j.jormas.2023.101422. Epub 2023 Feb 11.
10
Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.对于局部晚期头颈部鳞状细胞癌患者,手术切缘阳性的手术切除是否有益:一项使用组间研究0034和放射治疗肿瘤学组头颈部数据库的比较研究。
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1011-6. doi: 10.1016/0360-3016(93)90517-y.

本文引用的文献

1
Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types.11 种主要癌症类型的非姑息性放疗期间和放疗后 30 天内的死亡率全景。
Radiother Oncol. 2022 Feb;167:308-316. doi: 10.1016/j.radonc.2022.01.008. Epub 2022 Jan 13.
2
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.头颈部癌症患者的纵向健康效用和症状毒性轨迹。
Cancer. 2022 Feb 1;128(3):497-508. doi: 10.1002/cncr.33936. Epub 2021 Oct 1.
3
Ninety-day mortality after radiotherapy for head and neck cancer: Population-based comparison between rural and urban patients.
头颈部癌症放疗后 90 天死亡率:农村和城市患者的基于人群比较。
Head Neck. 2021 Nov;43(11):3306-3313. doi: 10.1002/hed.26819. Epub 2021 Jul 21.
4
Factors predictive of 90-day mortality after surgical resection for oral cavity cancer: Development of a recursive partitioning analysis for risk stratification.口腔癌手术后 90 天死亡率的预测因素:风险分层的递归分区分析的制定。
Head Neck. 2021 Sep;43(9):2731-2739. doi: 10.1002/hed.26740. Epub 2021 May 19.
5
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.头颈部癌症化疗的荟萃分析(MACH-NC):代表 MACH-NC 小组,对 107 项随机试验和 19805 名患者的最新更新。
Radiother Oncol. 2021 Mar;156:281-293. doi: 10.1016/j.radonc.2021.01.013. Epub 2021 Jan 27.
6
Predictive classifier for intensive treatment of head and neck cancer.头颈部癌症强化治疗的预测分类器。
Cancer. 2020 Dec 15;126(24):5263-5273. doi: 10.1002/cncr.33212. Epub 2020 Oct 5.
7
Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database.头颈部癌症根治性放疗后的早期死亡率 - 来自丹麦头颈部癌症组(DAHANCA)数据库的全国性分析。
Clin Oncol (R Coll Radiol). 2021 Jan;33(1):57-63. doi: 10.1016/j.clon.2020.07.004. Epub 2020 Jul 19.
8
Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?老年头颈部癌症患者的放射治疗:标准治疗在老年人中的价值如何?
Radiat Oncol. 2020 Feb 4;15(1):31. doi: 10.1186/s13014-020-1481-z.
9
Selection of Head and Neck Cancer Patients for Intensive Therapy.头颈部癌症患者的强化治疗选择。
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):157-166. doi: 10.1016/j.ijrobp.2019.09.011. Epub 2019 Sep 30.
10
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.列线图预测局部晚期头颈部癌症强化治疗的获益。
Clin Cancer Res. 2019 Dec 1;25(23):7078-7088. doi: 10.1158/1078-0432.CCR-19-1832. Epub 2019 Aug 16.